Aprocitentan and Sparsentan: Interaction Details
- Sparsentan
- Filspari
- Aprocitentan
- Tryvio
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Aprocitentan and Sparsentan interaction:
What Happens When You Take Aprocitentan With Sparsentan
What can happen when they are taken together (rated Contraindicated)
An increased risk of , syncope, , and changes in function (including acute renal failure)
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Sparsentan must not be given together with endothelin receptor (ERAs), as the combination may raise the risk of hypotension, syncope, hyperkalemia, and alterations in renal function, including acute renal failure. Any ERA therapy should be stopped before sparsentan is started.1
The Aprocitentan and Sparsentan Interaction, Explained
Sparsentan (Filspari) and aprocitentan (Tryvio) should not be taken together. Both medicines block endothelin receptors, and sparsentan also blocks the angiotensin receptor. Using them together might raise the chance of very low blood pressure, fainting, high potassium, and kidney problems, including sudden kidney failure.
This warning is based on how the drugs work, not on reports of harm in people taking both. Even so, it is taken seriously. If you were prescribed both, do not stop or change anything on your own. Talk with your pharmacist or doctor, who can sort out the safest plan for you.
(theoretical evidence). Sparsentan is a dual endothelin type A and angiotensin II type 1 receptor . Aprocitentan is a dual endothelin A/B receptor antagonist. is expected to add effects. The documented mechanism is unknown, and onset is unspecified.
- Potential outcomes: , syncope, , and changes in function including acute renal failure.
- Management: discontinue the ERA before starting sparsentan. Do not coadminister.
- Neither drug is a that changes the direction of the interaction. The concern is pharmacodynamic effect, not a change.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Aprocitentan and Sparsentan Interact
The likely mechanism
Unknown
“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.
When two medicines can each cause the same effect, here changes in blood pressure, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.
How to Manage the Aprocitentan and Sparsentan Interaction
The documented management is to avoid using these two medicines together. Aprocitentan (an endothelin receptor ) should be stopped before sparsentan is started.
- Do not stop or start either medicine on your own. Your prescriber will decide on the plan and timing.
- If you have both on your list, ask your pharmacist or prescriber to review them right away.
- Tell your care team if you feel dizzy, lightheaded, or faint, or notice changes in urination or swelling.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Aprocitentan or Sparsentan need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Aprocitentan and Sparsentan: Common Questions
How serious is the Aprocitentan and Sparsentan interaction?
It is rated . These should generally not be used together.
How is the Aprocitentan and Sparsentan interaction managed?
The documented management is to avoid using these two medicines together. Aprocitentan (an endothelin receptor ) should be stopped before sparsentan is started. Do not stop or start either medicine on your own. Your prescriber will decide on the plan and timing. If you have both on your list, ask your pharmacist or prescriber to review them right away. Tell your care team if you feel diz… Management is individual — always follow your own care team's guidance.
Who is at higher risk from the Aprocitentan and Sparsentan interaction?
The interaction record names this group as more likely to be affected:
- People with kidney problems
If this describes you, tell your pharmacist or prescriber.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Aprocitentan and Sparsentan Interaction
Ask in your own words about taking Aprocitentan and Sparsentan together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: FILSPARI® oral tablets, sparsentan oral tablets. Travere Therapeutics Inc, San Diego, CA, 2026. DailyMed
Other Serious Interactions of Aprocitentan and Sparsentan
Also serious with Sparsentan
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Sparsentan
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin EModerate
- Vitamin AModerate
- + 168 more
With Aprocitentan
- Activated CharcoalMajor
- WineMajor
- American HelleboreMajor
- American MistletoeMajor
- BeerMajor
- Siberian CockleburMajor
- TyramineMajor
- Vitamin B6Moderate
- + 181 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.